Chemical control of protein stability and function in living mice

被引:111
作者
Banaszynski, Laura A. [4 ]
Sellmyer, Mark A. [1 ,2 ,3 ,5 ]
Contag, Christopher H. [1 ,2 ,3 ]
Wandless, Thomas J. [5 ]
Thorne, Steve H. [1 ,2 ,3 ]
机构
[1] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA
[4] Stanford Univ, Dept Chem, Stanford, CA 94305 USA
[5] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nm.1754
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Conditional control of protein function in vivo offers great potential for deconvoluting the roles of individual proteins in complicated systems. We recently developed a method in which a small protein domain, termed a destabilizing domain, confers instability to fusion protein partners in cultured cells. Instability is reversed when a cell-permeable small molecule binds this domain. Here we describe the use of this system to regulate protein function in living mammals. We show regulation of secreted proteins and their biological activity with conditional secretion of an immunomodulatory cytokine, resulting in tumor burden reduction in mouse models. Additionally, we use this approach to control the function of a specific protein after systemic delivery of the gene that encodes it to a tumor, suggesting uses for enhancing the specificity and efficacy of targeted gene-based therapies. This method represents a new strategy to regulate protein function in living organisms with a high level of control.
引用
收藏
页码:1123 / 1127
页数:5
相关论文
共 30 条
[1]   Essential dosage-dependent functions of the transcription factor Yin Yang 1 in late embryonic development and cell cycle progression [J].
Affar, E ;
Gay, F ;
Shi, YJ ;
Liu, HF ;
Huarte, M ;
Wu, S ;
Collins, T ;
Li, E ;
Shi, Y .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (09) :3565-3581
[2]   Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors [J].
Alcamí, A ;
Khanna, A ;
Paul, NL ;
Smith, GL .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :949-959
[3]   High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: Analysis of 270 patients treated between 1985 and 1993 [J].
Atkins, MB ;
Lotze, MT ;
Dutcher, JP ;
Fisher, RI ;
Weiss, G ;
Margolin, K ;
Abrams, J ;
Sznol, M ;
Parkinson, D ;
Hawkins, M ;
Paradise, C ;
Kunkel, L ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2105-2116
[4]   A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules [J].
Banaszynski, Laura A. ;
Chen, Lin-chun ;
Maynard-Smith, Lystranne A. ;
Ooi, A. G. Lisa ;
Wandless, Thomas J. .
CELL, 2006, 126 (05) :995-1004
[5]   Of mice and models: improved animal models for biomedical research [J].
Bockamp, E ;
Maringer, M ;
Spangenberg, C ;
Fees, S ;
Fraser, S ;
Eshkind, L ;
Oesch, F ;
Zabel, B .
PHYSIOLOGICAL GENOMICS, 2002, 11 (03) :115-132
[6]   FORMATION OF GERM-LINE CHIMERAS FROM EMBRYO-DERIVED TERATOCARCINOMA CELL-LINES [J].
BRADLEY, A ;
EVANS, M ;
KAUFMAN, MH ;
ROBERTSON, E .
NATURE, 1984, 309 (5965) :255-256
[7]   A MAMMALIAN PROTEIN TARGETED BY G1-ARRESTING RAPAMYCIN-RECEPTOR COMPLEX [J].
BROWN, EJ ;
ALBERS, MW ;
SHIN, TB ;
ICHIKAWA, K ;
KEITH, CT ;
LANE, WS ;
SCHREIBER, SL .
NATURE, 1994, 369 (6483) :756-758
[8]   TARGETED CORRECTION OF A MUTANT HPRT GENE IN MOUSE EMBRYONIC STEM-CELLS [J].
DOETSCHMAN, T ;
GREGG, RG ;
MAEDA, N ;
HOOPER, ML ;
MELTON, DW ;
THOMPSON, S ;
SMITHIES, O .
NATURE, 1987, 330 (6148) :576-578
[9]   TEMPORAL CONTROL OF GENE-EXPRESSION IN TRANSGENIC MICE BY A TETRACYCLINE-RESPONSIVE PROMOTER [J].
FURTH, PA ;
STONGE, L ;
BOGER, H ;
GRUSS, P ;
GOSSEN, M ;
KISTNER, A ;
BUJARD, H ;
HENNIGHAUSEN, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (20) :9302-9306
[10]   Overview of interleukin-2 function, production and clinical applications [J].
Gaffen, SL ;
Liu, KD .
CYTOKINE, 2004, 28 (03) :109-123